BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 28601268)

  • 1. The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue Therapy on Recovery From Copperhead Snake Envenomation: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.
    Gerardo CJ; Quackenbush E; Lewis B; Rose SR; Greene S; Toschlog EA; Charlton NP; Mullins ME; Schwartz R; Denning D; Sharma K; Kleinschmidt K; Bush SP; Ryan S; Gasior M; Anderson VE; Lavonas EJ
    Ann Emerg Med; 2017 Aug; 70(2):233-244.e3. PubMed ID: 28601268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite.
    Lavonas EJ; Gerardo CJ; O'Malley G; Arnold TC; Bush SP; Banner W; Steffens M; Kerns WP
    Ann Emerg Med; 2004 Feb; 43(2):200-6. PubMed ID: 14747809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early administration of Fab antivenom resulted in faster limb recovery in copperhead snake envenomation patients.
    Anderson VE; Gerardo CJ; Rapp-Olsson M; Bush SP; Mullins ME; Greene S; Toschlog EA; Quackenbush E; Rose SR; Schwartz RB; Charlton NP; Lewis B; Kleinschmidt KC; Sharma K; Lavonas EJ
    Clin Toxicol (Phila); 2019 Jan; 57(1):25-30. PubMed ID: 30175628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery from Copperhead Snake Envenomation: Role of Age, Sex, Bite Location, Severity, and Treatment.
    Lavonas EJ; Burnham RI; Schwarz J; Quackenbush E; Lewis B; Rose SR; Greene S; Toschlog EA; Charlton NP; Mullins ME; Schwartz R; Denning D; Sharma K; Kleinschmidt K; Bush SP; Anderson VE; Ginde AA; Gerardo CJ
    J Med Toxicol; 2020 Jan; 16(1):17-23. PubMed ID: 31482319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Events in the Efficacy of Crotalidae Polyvalent Immune Fab Antivenom vs Placebo in Recovery from Copperhead Snakebite Trial.
    Mullins ME; Gerardo CJ; Bush SP; Rose SR; Greene S; Quackenbush EB; Lewis B; Anderson VE; Kleinschmidt KC; Schwarz RB; Charlton NP; Toschlog EA; Sharma K; Denning DA; Lavonas EJ
    South Med J; 2018 Dec; 111(12):716-720. PubMed ID: 30512122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of FabAV use in copperhead envenomation.
    Ramirez-Cueva F; Larsen A; Knowlton E; Baab K; Rainey Kiehl R; Hendrix A; Condren M; Woslager M
    Clin Toxicol (Phila); 2022 May; 60(5):609-614. PubMed ID: 34989644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical considerations in design of a study to evaluate a US Food and Drug Administration-approved indication: antivenom versus placebo for copperhead envenomation.
    Gerardo CJ; Lavonas EJ; McKinney RE
    Clin Trials; 2014 Oct; 11(5):560-4. PubMed ID: 25055811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Response to "The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue Therapy on Recovery from Copperhead Snake Envenomation".
    Chiang W; Harding SA; Tassin SA; Nguyen V; Su M
    Ann Emerg Med; 2017 Dec; 70(6):930-931. PubMed ID: 29157700
    [No Abstract]   [Full Text] [Related]  

  • 9. Coagulation parameters in copperhead compared to other Crotalinae envenomation: secondary analysis of the F(ab')
    Gerardo CJ; Vissoci JR; Brown MW; Bush SP
    Clin Toxicol (Phila); 2017 Feb; 55(2):109-114. PubMed ID: 27806644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late hemotoxicity following North American rattlesnake envenomation treated with crotalidae immune F(ab')
    Spyres MB; Padilla GK; Gerkin RD; Hoyte CO; Wolk BJ; Ruha AM;
    Clin Toxicol (Phila); 2022 Jul; 60(7):838-842. PubMed ID: 35261320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked Hypofibrinogenemia and Gastrointestinal Bleeding After Copperhead (Agkistrodon contortrix) Envenomation.
    Kopec KT; Yen M; Bitner M; Evans CS; Gerardo CJ
    Wilderness Environ Med; 2015 Dec; 26(4):488-90. PubMed ID: 26432425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American rattlesnake bite patients.
    Bush SP; Seifert SA; Oakes J; Smith SD; Phan TH; Pearl SR; Reibling ET
    Toxicon; 2013 Jul; 69():29-37. PubMed ID: 23474267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of recovery from copperhead snake envenomation: an observational study.
    Lavonas EJ; Gerardo CJ;
    BMC Emerg Med; 2015 May; 15():9. PubMed ID: 25975429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of venom-induced tissue injury in copperhead snakebite patients: a post hoc sub-group analysis of a clinical trial comparing F(ab')
    Gerardo CJ; Keyler DE; Rapp-Olson M; Dart RC
    Clin Toxicol (Phila); 2022 Apr; 60(4):521-523. PubMed ID: 34590543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe adverse drug reaction following Crotalidae Polyvalent Immune Fab (Ovine) administration for copperhead snakebite.
    Lepak MR; Bochenek SH; Bush SP
    Ann Pharmacother; 2015 Jan; 49(1):145-9. PubMed ID: 25341425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antivenom Treatment Is Associated with Fewer Patients using Opioids after Copperhead Envenomation.
    Freiermuth CE; Lavonas EJ; Anderson VE; Kleinschmidt KC; Sharma K; Rapp-Olsson M; Gerardo C;
    West J Emerg Med; 2019 May; 20(3):497-505. PubMed ID: 31123552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial.
    Bush SP; Ruha AM; Seifert SA; Morgan DL; Lewis BJ; Arnold TC; Clark RF; Meggs WJ; Toschlog EA; Borron SW; Figge GR; Sollee DR; Shirazi FM; Wolk R; de Chazal I; Quan D; García-Ubbelohde W; Alagón A; Gerkin RD; Boyer LV
    Clin Toxicol (Phila); 2015 Jan; 53(1):37-45. PubMed ID: 25361165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of delayed use of crotalidae polyvalent immune Fab (ovine) antivenom.
    Bebarta V; Dart RC
    J Toxicol Clin Toxicol; 2004; 42(3):321-4. PubMed ID: 15362603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presumed Copperhead Snakebite and Antivenom Administration in the Third Trimester.
    Yano J; Zerden M; German B
    Wilderness Environ Med; 2019 Dec; 30(4):446-449. PubMed ID: 31699647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically Significant Envenomation From Postmortem Copperhead (Agkistrodon contortrix).
    Emswiler MP; Griffith FP; Cumpston KL
    Wilderness Environ Med; 2017 Mar; 28(1):43-45. PubMed ID: 27876196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.